RCEL Quote, Financials, Valuation and Earnings

Retractable Technologies has a net margin of -74.86% compared to AVITA Medical's net margin of -18.58%. AVITA Medical's return on equity of -415.55% beat Retractable Technologies's return on equity of -16.83%.

AVITA Medical has a consensus price target of $16.06, signalling upside risk potential of 129.14%. On the other hand Retractable Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that AVITA Medical has higher upside potential than Retractable Technologies, analysts believe AVITA Medical is more attractive than Retractable Technologies.

AVITA Medical has a beta of 1.741, which suggesting that the stock is 74.135% more volatile than S&P 500. In comparison Retractable Technologies has a beta of 1.650, suggesting its more volatile than the S&P 500 by 64.995%.

AVITA Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Retractable Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AVITA Medical pays -- of its earnings as a dividend. Retractable Technologies pays out -1.94% of its earnings as a dividend.

AVITA Medical quarterly revenues are $18.5M, which are larger than Retractable Technologies quarterly revenues of $10.3M. AVITA Medical's net income of -$13.9M is lower than Retractable Technologies's net income of -$1.9M. Notably, AVITA Medical's price-to-earnings ratio is -- while Retractable Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVITA Medical is 2.55x versus 0.69x for Retractable Technologies. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX has a net margin of -74.86% compared to AVITA Medical's net margin of -1226.82%. AVITA Medical's return on equity of -415.55% beat VolitionRX's return on equity of --.

AVITA Medical has a consensus price target of $16.06, signalling upside risk potential of 129.14%. On the other hand VolitionRX has an analysts' consensus of $2.92 which suggests that it could grow by 525.05%. Given that VolitionRX has higher upside potential than AVITA Medical, analysts believe VolitionRX is more attractive than AVITA Medical.

AVITA Medical has a beta of 1.741, which suggesting that the stock is 74.135% more volatile than S&P 500. In comparison VolitionRX has a beta of 0.997, suggesting its less volatile than the S&P 500 by 0.339%.

AVITA Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AVITA Medical pays -- of its earnings as a dividend. VolitionRX pays out -- of its earnings as a dividend.

AVITA Medical quarterly revenues are $18.5M, which are larger than VolitionRX quarterly revenues of $474.5K. AVITA Medical's net income of -$13.9M is lower than VolitionRX's net income of -$5.8M. Notably, AVITA Medical's price-to-earnings ratio is -- while VolitionRX's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVITA Medical is 2.55x versus 32.82x for VolitionRX. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision has a net margin of -74.86% compared to AVITA Medical's net margin of -4291.67%. AVITA Medical's return on equity of -415.55% beat Catheter Precision's return on equity of -65.84%.

AVITA Medical has a consensus price target of $16.06, signalling upside risk potential of 129.14%. On the other hand Catheter Precision has an analysts' consensus of -- which suggests that it could grow by 551.47%. Given that Catheter Precision has higher upside potential than AVITA Medical, analysts believe Catheter Precision is more attractive than AVITA Medical.

AVITA Medical has a beta of 1.741, which suggesting that the stock is 74.135% more volatile than S&P 500. In comparison Catheter Precision has a beta of -0.870, suggesting its less volatile than the S&P 500 by 187.02%.

AVITA Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AVITA Medical pays -- of its earnings as a dividend. Catheter Precision pays out -- of its earnings as a dividend.

AVITA Medical quarterly revenues are $18.5M, which are larger than Catheter Precision quarterly revenues of $96K. AVITA Medical's net income of -$13.9M is lower than Catheter Precision's net income of -$4.1M. Notably, AVITA Medical's price-to-earnings ratio is -- while Catheter Precision's PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVITA Medical is 2.55x versus 2.11x for Catheter Precision. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings has a net margin of -74.86% compared to AVITA Medical's net margin of -10.04%. AVITA Medical's return on equity of -415.55% beat Xtant Medical Holdings's return on equity of -35.34%.

AVITA Medical has a consensus price target of $16.06, signalling upside risk potential of 129.14%. On the other hand Xtant Medical Holdings has an analysts' consensus of $1.75 which suggests that it could grow by 193.33%. Given that Xtant Medical Holdings has higher upside potential than AVITA Medical, analysts believe Xtant Medical Holdings is more attractive than AVITA Medical.

AVITA Medical has a beta of 1.741, which suggesting that the stock is 74.135% more volatile than S&P 500. In comparison Xtant Medical Holdings has a beta of -0.124, suggesting its less volatile than the S&P 500 by 112.425%.

AVITA Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AVITA Medical pays -- of its earnings as a dividend. Xtant Medical Holdings pays out -- of its earnings as a dividend.

AVITA Medical quarterly revenues are $18.5M, which are smaller than Xtant Medical Holdings quarterly revenues of $31.5M. AVITA Medical's net income of -$13.9M is lower than Xtant Medical Holdings's net income of -$3.2M. Notably, AVITA Medical's price-to-earnings ratio is -- while Xtant Medical Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVITA Medical is 2.55x versus 0.68x for Xtant Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.